GlassScriptPhysician profile
Elizabeth B Snajdar
NPI 1376005926
$3,347.25
in general payments reported to CMS, 2019-2025
21 companies · $2,278 in 2025
The $2,278 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2021: $93.09 · 2022: $153 · 2023: $135 · 2024: $542 · 2025: $2,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,555 · Food and Beverage: $1,138 · Travel and Lodging: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,554.99 |
| Food and Beverage | $1,138.34 |
| Travel and Lodging | $262.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,818.19 | 2024-2025 | |
| Coloplast Corp | $280.41 | 2019-2023 | Porges Coloplast |
| Medtronic, INC. | $263.70 | 2021-2024 | Interstim |
| Pfizer INC. | $184.74 | 2024-2025 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $100.28 | 2024 | Bulkamid |
| Sumitomo Pharma America, INC. | $72.80 | 2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $69.30 | 2025 | Carvykti, Rybrevant |
| Boston Scientific Corporation | $59.43 | 2025 | Lithoclast |
| Baxter Healthcare | $58.84 | 2025 | Tisseel |
| Seagen INC. | $54.99 | 2025 | |
| Convatec INC. | $43.64 | 2024 | |
| Abbvie INC. | $38.78 | 2025 | |
| Urogen Pharma, INC. | $31.60 | 2025 | |
| Astellas Pharma US INC | $23.49 | 2024 | Xtandi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $21.58 | 2025 | Jatenzo |
| Dendreon Pharmaceuticals LLC | $21.50 | 2025 | Provenge |
| Olympus America INC. | $18.99 | 2024 | Itind System |
| Procept Biorobotics Corporation | $16.82 | 2025 | |
| Endo USA, INC. | $15.35 | 2024 | Xiaflex |
| Antares Pharma, INC. | $15.15 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Snajdar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.